AHA: Allogeneic stem cells OK in ischemic cardiomyopathy
(HealthDay)—For patients with ischemic cardiomyopathy (ICM), allogeneic bone marrow-derived mesenchymal stem cells (MSCs) are safe; and delivery of bone marrow mononuclear cells (BMC) to patients with ST-segment elevation ...
Nov 7, 2012
0
0